The effect of magnesium in controlling asthma

Phase 2

• Conditions: Asthma.; Asthma, unspecified, Acute severe asthma; J45.9,J46

• Registration Number: IRCT20170827035935N2
• Lead Sponsor: Vice chancellor for research of Mazandaran University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with asthma

Exclusion Criteria

Use of oral corticosteroids
Use Diuretics
Renal failure
Congestive heart failure
Use of magnesium supplement in the past quarter
History of using cigarettes
Pregnancy
The decision to have a pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of asthma. Timepoint: At the beginning of the study (before the intervention) and at weeks 4, 8 and 12 after the intervention. Method of measurement: PEFR measurements by peak flow meter.;FEV1/FVC. Timepoint: Before and immediately after the intervention. Method of measurement: Spirometry.;The number of asthma attacks. Timepoint: At the beginning of the study (before the intervention) and at weeks 4, 8 and 12 after the intervention. Method of measurement: Ask the patient.;ACT-Score. Timepoint: At the beginning of the study (before the intervention) and at weeks 4, 8 and 12 after the intervention. Method of measurement: ACT questionnaire.;FEV1. Timepoint: Before and immediately after the intervention. Method of measurement: Spirometry.;FVC. Timepoint: Before and immediately after the intervention. Method of measurement: Spirometry.

Secondary Outcome Measures

Name	Time	Method
-. Timepoint: -. Method of measurement: -.